{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:52:55Z","timestamp":1788310375124,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1097\/01.bor.0000198007.73320.6e","type":"journal-article","created":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T04:01:29Z","timestamp":1134360089000},"page":"96-100","source":"Crossref","is-referenced-by-count":33,"title":["Musculoskeletal manifestations and autoimmune diseases related to new biologic agents"],"prefix":"10.1097","volume":"18","author":[{"given":"Boulos","family":"Haraoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Keystone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210128","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor \u03b1","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"key":"R2-15-20210128","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double- stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor \u03b1","volume":"43","author":"Charles","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R3-15-20210128","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.10876","article-title":"Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy","volume":"48","author":"De Rycke","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R4-15-20210128","first-page":"2557","article-title":"Induction of autoantibodies during prolonged treatment with infliximab","volume":"30","author":"Louis","year":"2003","journal-title":"J Rheumatol"},{"key":"R5-15-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0016-5085(03)00701-7","article-title":"Autoimmunity with antitumor necrosis factor \u03b1 treatment in Crohn's disease: A prospective cohort study","volume":"125","author":"Vermeire","year":"2003","journal-title":"Gastroenterology"},{"key":"R6-15-20210128","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/rheumatology\/41.10.1109","article-title":"Rescue of combination therapy failures using infliximab while maintaining the combination or monotherapy with methotrexate: results of an open trial","volume":"41","author":"Ferracioli","year":"2002","journal-title":"Rheumatology"},{"key":"R7-15-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2796.2003.01298.x","article-title":"Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor \u03b1 antibodies","volume":"255","author":"D'Auria","year":"2004","journal-title":"J Int Med"},{"key":"R8-15-20210128","first-page":"2287","article-title":"Anti-tumor necrosis factor \u03b1 therapy-induced vasculitis: Case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"key":"R9-15-20210128","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/rheumatology\/41.6.631","article-title":"Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study","volume":"41","author":"Kiely","year":"2002","journal-title":"Rheumatology"},{"key":"R10-15-20210128","first-page":"328","article-title":"Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis.","volume":"22","author":"Godinho","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R11-15-20210128","first-page":"1955","article-title":"Leukocytoclastic vasculitis associated with Tumor Necrosis Factor blocking agents","volume":"31","author":"Mohan","year":"2004","journal-title":"J Rheumatol"},{"key":"R12-15-20210128","first-page":"2079","article-title":"Sensory neuroathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis","volume":"31","author":"Richette","year":"2004","journal-title":"J Rheumatol"},{"key":"R14-15-20210128","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/ard.2003.018093","article-title":"Treatment with tumor necrosis factor antagonists in patients with rheumatoid arthritis induced anticardiolipin antibodies","volume":"63","author":"Jonsdotter","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R16-15-20210128","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.21190","article-title":"Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis","volume":"52","author":"De Rycke","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R17-15-20210128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","article-title":"Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFalpha","volume":"64","author":"Eriksson","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R18-15-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","article-title":"Drug induced systemic lupus erythematosus associated with etanercept therapy","volume":"359","author":"Shakoor","year":"2002","journal-title":"Lancet"},{"key":"R19-15-20210128","doi-asserted-by":"crossref","first-page":"634","DOI":"10.7326\/0003-4819-131-8-199910190-00031","article-title":"Autoimmune skin rashes associated with etanercept for rheumatoid arthritis","volume":"131","author":"Brion","year":"1999","journal-title":"Ann Intern Med"},{"key":"R20-15-20210128","first-page":"175","article-title":"Two cases of etanercept induced systemic lupus erythematosus in patients with rheumatoid arthritis [abstract]","volume":"60","author":"DeBandt","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R21-15-20210128","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(02)09800-8","article-title":"Drug induced systemic lupus and anti-TNFalpha blockers","volume":"360","author":"Mohan","year":"2002","journal-title":"Lancet"},{"key":"R22-15-20210128","first-page":"740","article-title":"Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept","volume":"32","author":"Mor","year":"2005","journal-title":"J Rheumatol"},{"key":"R23-15-20210128","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNFalpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R24-15-20210128","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","article-title":"A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers, etanercept, infliximab and adalimumab","volume":"15","author":"Scheinfeld","year":"2004","journal-title":"J Dermatology Treat"},{"key":"R25-15-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3083.2005.01570.x","article-title":"Immunology of cutaneous vasculitis associated with both etanercept and infliximab","volume":"61","author":"Strivastava","year":"2005","journal-title":"Scand J Immunol"},{"key":"R26-15-20210128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5414\/CNP62234","article-title":"Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis","volume":"62","author":"Doulton","year":"2004","journal-title":"Clin Nephrol"},{"key":"R27-15-20210128","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor (alpha) therapy for inflammatory arthritidies","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R28-15-20210128","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1034\/j.1600-0609.2003.00115.x","article-title":"Aplastic anemia following administration of a tumor necrosis factor inhibitor","volume":"71","author":"Kuruvilla","year":"2003","journal-title":"Eur J Hematol"},{"key":"R29-15-20210128","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"key":"R30-15-20210128","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.61.6.565","article-title":"Silent thyroiditis associated with etanercept in rheumatoid arthritis","volume":"61","author":"Andres","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R31-15-20210128","first-page":"752","article-title":"Development of Crohn's disease in a patient taking etanercept","volume":"32","author":"Oh","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001648-201205000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:09:12Z","timestamp":1785856152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200601000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.bor.0000198007.73320.6e","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}